Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $314.91.
A number of equities research analysts have weighed in on the company. Argus assumed coverage on Axon Enterprise in a research report on Wednesday, March 13th. They set a “buy” rating and a $380.00 target price for the company. StockNews.com lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. TheStreet downgraded shares of Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. Finally, Morgan Stanley boosted their price objective on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday.
View Our Latest Research Report on Axon Enterprise
Institutional Investors Weigh In On Axon Enterprise
Axon Enterprise Trading Up 1.6 %
NASDAQ AXON opened at $313.30 on Thursday. The stock has a market cap of $23.64 billion, a PE ratio of 136.22 and a beta of 0.93. Axon Enterprise has a 12 month low of $175.37 and a 12 month high of $329.87. The company’s 50-day moving average price is $305.09 and its 200-day moving average price is $262.90. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The business had revenue of $432.14 million for the quarter, compared to the consensus estimate of $418.97 million. Equities research analysts forecast that Axon Enterprise will post 2.44 earnings per share for the current year.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Using the MarketBeat Dividend Yield Calculator
- The 3 Hottest Insiders Buys This Month
- CD Calculator: Certificate of Deposit Calculator
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.